Cambridge Investment Research Advisors’s AllianceBernstein AB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.17M Buy
57,835
+3,756
+7% +$148K 0.01% 1529
2025
Q4
$2.08M Sell
54,079
-7,665
-12% -$304K 0.01% 1484
2025
Q3
$2.36M Buy
61,744
+1,915
+3% +$76.6K 0.01% 1381
2025
Q2
$2.44M Buy
59,829
+427
+0.7% +$16.7K 0.01% 1278
2025
Q1
$2.28M Sell
59,402
-8,609
-13% -$324K 0.01% 1263
2024
Q4
$2.52M Buy
68,011
+3,386
+5% +$123K 0.01% 1194
2024
Q3
$2.25M Sell
64,625
-8,979
-12% -$307K 0.01% 1262
2024
Q2
$2.49M Sell
73,604
-13,359
-15% -$447K 0.01% 1143
2024
Q1
$3.02M Buy
86,963
+139
+0.2% +$4.62K 0.01% 1027
2023
Q4
$2.69M Buy
86,824
+16,478
+23% +$485K 0.01% 1022
2023
Q3
$2.13M Sell
70,346
-20,909
-23% -$664K 0.01% 1092
2023
Q2
$2.94M Buy
91,255
+2,580
+3% +$88.3K 0.01% 938
2023
Q1
$3.24M Sell
88,675
-91,699
-51% -$3.45M 0.02% 855
2022
Q4
$6.2M Sell
180,374
-6,922
-4% -$256K 0.03% 511
2022
Q3
$6.57M Buy
187,296
+12,042
+7% +$509K 0.04% 456
2022
Q2
$7.29M Buy
175,254
+10,628
+6% +$446K 0.04% 432
2022
Q1
$7.74M Buy
164,626
+8,649
+6% +$402K 0.04% 466
2021
Q4
$7.62M Sell
155,977
-2,283
-1% -$119K 0.03% 482
2021
Q3
$7.85M Sell
158,260
-1,697
-1% -$83.6K 0.04% 430
2021
Q2
$7.45M Buy
159,957
+6,500
+4% +$283K 0.04% 473
2021
Q1
$6.14M Buy
153,457
+60,223
+65% +$2.26M 0.03% 494
2020
Q4
$3.15M Buy
93,234
+42,275
+83% +$1.34M 0.02% 692
2020
Q3
$1.38M Sell
50,959
-1,259
-2% -$35.2K 0.01% 999
2020
Q2
$1.42M Buy
52,218
+1,951
+4% +$45.3K 0.01% 930
2020
Q1
$934K Buy
50,267
+1,666
+3% +$49.2K 0.01% 1006
2019
Q4
$1.47M Sell
48,601
-2,143
-4% -$62.5K 0.01% 945
2019
Q3
$1.49M Sell
50,744
-7,189
-12% -$209K 0.01% 870
2019
Q2
$1.72M Buy
57,933
+65
+0.1% +$1.89K 0.02% 778
2019
Q1
$1.67M Buy
57,868
+19,361
+50% +$568K 0.02% 787
2018
Q4
$1.05M Sell
38,507
-14,823
-28% -$427K 0.01% 912
2018
Q3
$1.62M Buy
53,330
+3,598
+7% +$107K 0.02% 768
2018
Q2
$1.42M Sell
49,732
-216
-0.4% -$5.98K 0.02% 787
2018
Q1
$1.34M Buy
49,948
+19,119
+62% +$510K 0.02% 792
2017
Q4
$772K Buy
30,829
+9,869
+47% +$249K 0.01% 1046
2017
Q3
$509K Buy
20,960
+667
+3% +$16.1K 0.01% 1248
2017
Q2
$480K Buy
20,293
+4,086
+25% +$91.5K 0.01% 1224
2017
Q1
$370K Buy
16,207
+541
+3% +$12.5K 0.01% 1242
2016
Q4
$367K Buy
15,666
+422
+3% +$9.53K 0.01% 1168
2016
Q3
$348K Sell
15,244
-2,899
-16% -$65.6K 0.01% 1217
2016
Q2
$423K Sell
18,143
-1,335
-7% -$31.1K 0.01% 1011
2016
Q1
$456K Sell
19,478
-8,985
-32% -$182K 0.01% 947
2015
Q4
$679K Buy
28,463
+2,228
+8% +$56.1K 0.02% 713
2015
Q3
$698K Sell
26,235
-3,266
-11% -$89.6K 0.02% 616
2015
Q2
$871K Buy
29,501
+7,516
+34% +$233K 0.02% 559
2015
Q1
$679K Buy
21,985
+2,418
+12% +$65.8K 0.02% 657
2014
Q4
$505K Buy
19,567
+5,536
+39% +$142K 0.02% 774
2014
Q3
$365K Buy
14,031
+2,236
+19% +$59.8K 0.01% 978
2014
Q2
$305K Buy
+11,795
New +$294K 0.01% 1001

Other funds holding AB

Cambridge Investment Research Advisors's AB Position: Q1 2026 in Review

Cambridge Investment Research Advisors increased its AllianceBernstein (AB) stake by 6.9% in Q1 2026, buying an estimated $148K and bringing the position to 57,835 shares worth $2.17M. The position accounts for 0.01% of the portfolio, ranked #1529.

Cambridge Investment Research Advisors first reported a position in AB in Q2 2014 and has held it in 48 quarters since. The position peaked at $7.85M in Q3 2021. 285 funds tracked by Wall St. Rank hold AB as of Q1 2026.

  • Cambridge Investment Research Advisors held 57,835 shares of AllianceBernstein worth $2.17M as of Q1 2026.
  • Cambridge Investment Research Advisors bought 3,756 AllianceBernstein shares in Q1 2026, an estimated $148K.
  • AllianceBernstein made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #1529 holding.
  • Cambridge Investment Research Advisors first reported a position in AllianceBernstein in Q2 2014 and has held it in 48 quarters since.
  • Cambridge Investment Research Advisors's AllianceBernstein position peaked at $7.85M in Q3 2021.
  • 285 funds tracked by Wall St. Rank held AllianceBernstein as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.